Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Industry Valuation for the Skin Booster Sector?

The market for kinase inhibitors has seen impressive growth recently. The market value will increase from $62.75 billion in 2024 to $67.21 billion in 2025, reflecting a Compound Annual Growth Rate (CAGR) of 7.1%. Factors contributing to the historical growth include a higher incidence of cancer, developments in targeted therapy, increasing healthcare spending, regulatory approval for new kinase inhibitors, and a rising trend towards personalized medicine.

The market size of kinase inhibitors is projected to witness robust expansion in the upcoming years. The market is forecasted to increase to “$88.56 billion by 2029, registering a compound annual growth rate (CAGR) of 7.1%.” This impending growth in the forecasted period is due to factors such as continuous research and development activities, the launch of new kinase inhibitors, the extension of uses beyond oncology, an upswing in biotech investment, and a heightened awareness of precision medicine. Future trends encompassing this period comprise the enlargement of precision oncology treatments, the crafting of combined therapies, a heightened spotlight on rare and tricky-to-treat cancers, progress in drug development driven by biomarkers, and a rising adoption of next-gen sequencing technologies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15841&type=smp

What Forces Are Driving The Growth Of The Skin Booster Market?

The surge in the demand for wrinkles treatment is anticipated to fuel the expansion of the skin booster market. The term “wrinkle treatment” pertains to the procedures used to alleviate the look of creases, folds or ridges in the skin, commonly employing creams, laser therapy, Botox and other methods, in an effort to augment beauty. Skin boosters, which primarily use hyaluronic acid injections to enhance skin texture, elasticity, and moisture levels by boosting hydration and skin volume, are a popular choice in wrinkle treatment, resulting in a more youthful look. For example, as reported by the UK-based British Association of Aesthetic Plastic Surgeons, the number of cosmetic procedures in March 2023 reached 31,057, marking an increase of 102% compared to the previous year. Hence, the rising demand for wrinkle treatment is bolstering the growth of the skin booster market.

The kinase inhibitors market covered in this report is segmented –

1) By Type: Tyrosine Kinase Inhibitors, Multikinase Inhibitors, mTOR Kinase Inhibitors, Other Types

2) By Route of Administration: Oral, Parenteral, Other Routes

3) By Application: Oncology, Inflammatory Diseases

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

5) By End User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Tyrosine Kinase Inhibitors: EGFR Inhibitors, HER2 Inhibitors, BCR-ABL Inhibitors, Other Tyrosine Kinase Inhibitors

2) By Multikinase Inhibitors: VEGFR Inhibitors, PDGFR Inhibitors, FGFR Inhibitors, Other Multikinase Inhibitors

3) By MTOR Kinase Inhibitors: Everolimus, Temsirolimus, Other MTOR Kinase Inhibitors

4) By Other Types: JAK Inhibitors, ROCK Inhibitors, CDK Inhibitors, Other Kinase Inhibitors

Which Emerging Trends And Strategic Shifts Are Shaping The Skin Booster Market?

Key players in the kinase inhibitors market are focusing on the discovery of selective tyrosine kinase 2 (TYK2) inhibitors, aiming to satisfy unfulfilled medical requirements for auto-immune and inflammatory disease treatment. These selective TYK2 inhibitors are known to modulate immune responses and minimize inflammation, thereby optimizing the body’s capacity to target and neutralize cancer cells as well as discourage tumor development. For example, In September 2022, The U.S. Food and Drug Administration (FDA) endorsed Sotyktu (deucravacitinib), a product of Bristol-Myers Squibb Company, a pharmaceutical firm based in the US. Sotyktu is an orally administered selective TYK2 inhibitor intended for adult patients suffering from moderate to severe plaque psoriasis requiring systemic therapy or phototherapy. The arrival of Sotyktu marks a significant milestone in the treatment of plaque psoriasis, providing a fresh alternative for patients who might not have experienced sufficient improvement with existing therapies.

Which Companies Currently Dominate The Competitive Landscape In The Skin Booster Industry?

Major companies operating in the kinase inhibitors market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bristol-Myers Squibb Company, AstraZeneca Plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Cipla Inc., Dr. Reddy’s Laboratories Ltd., Endo International Inc., Amneal Pharmaceuticals LLC, Lupin Limited, Exelixis Inc., Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Hutchison China MediTech Limited, Akorn Incorporated, Ocular Therapeutix Inc., Sierra Oncology Inc

https://www.thebusinessresearchcompany.com/report/kinase-inhibitors-global-market-report

Which Geographic Regions Are Driving Demand In The Skin Booster Market?

Asia-Pacific was the largest region in the kinase inhibitors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kinase inhibitors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15841&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model